Lakeside Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Lakeside Advisors's ABBV Position: Q2 2026 in Review
Lakeside Advisors reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $64.5K and leaving 15,376 shares worth $3.87M. The position accounts for 2.44% of the portfolio, ranked #13.
Lakeside Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,495 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Lakeside Advisors held 15,376 shares of AbbVie worth $3.87M as of Q2 2026.
- Lakeside Advisors sold 300 AbbVie shares in Q2 2026, an estimated $64.5K.
- AbbVie made up 2.44% of Lakeside Advisors's portfolio in Q2 2026, its #13 holding.
- Lakeside Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 2,495 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.